v3.26.1
Consolidated Statements of Changes in Equity (Deficit) - USD ($)
Common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Non - controlling interest
Total
Balance at Mar. 31, 2024 $ 105 $ 43,951,069 $ (41,384,268) $ (1,672,005) $ 3,159,103 $ 4,054,004
Balance (in Shares) at Mar. 31, 2024 [1] 1,051,804          
Net loss (3,725,305) 44,493 (3,680,812)
Foreign currency translation adjustments (25,159) 223 (24,936)
Balance at Mar. 31, 2025 $ 105 43,951,069 (45,109,573) (1,697,164) 3,203,819 348,256
Balance (in Shares) at Mar. 31, 2025 [1] 1,051,804          
Net loss (5,270,200) (101,304) (5,371,504)
Exercise of November 2021 Private Placement Warrants $ 7 341,244 341,251
Exercise of November 2021 Private Placement Warrants (in Shares) [1] 73,357          
Cashless exercise of November 2021 Investor warrants into common stock $ 135 (135)
Cashless exercise of November 2021 Investor warrants into common stock (in Shares) [1] 1,345,820          
Fair value of derivative liabilities upon exercise of warrants 4,099 4,099
Conversion of preferred stock into common stock $ 4 191,417 191,421
Conversion of preferred stock into common stock (in Shares) [1] 36,471          
Additional shares of common stock round up adjustment due to retroactive effect of 1-for-10 reverse stock split
Additional shares of common stock round up adjustment due to retroactive effect of 1-for-10 reverse stock split (in Shares) [1] 37          
Issuance of common stock in PIPE Offering, net of issuance costs $ 50 659,942 659,992
Issuance of common stock in PIPE Offering, net of issuance costs (in Shares) [1] 500,000          
Issuance of common stock for consulting services $ 20 249,980 250,000
Issuance of common stock for consulting services (in Shares) [1] 200,000          
Issuance of common stock in registered direct offering with concurrent private placement warrants $ 135 (135)
Issuance of common stock in registered direct offering with concurrent private placement warrants (in Shares) 1,350,000          
Deconsolidation of discontinued operations 866,908 323,272 1,190,180
Foreign currency translation adjustments (21,313) (154,848) (176,161)
Balance at Mar. 31, 2026 $ 456 $ 45,397,481 $ (50,379,773) $ (851,569) $ 3,270,939 $ (2,562,466)
Balance (in Shares) at Mar. 31, 2026 [1] 4,557,489          
[1] Giving retroactive effect to the 1-for-10 reverse stock split effected on July 29, 2025